Nicotine and novel tobacco products drive adverse cardiac remodeling and dysfunction in preclinical studies
BackgroundThe heart undergoes structural and functional changes in response to injury and hemodynamic stress known as cardiac remodeling. Cardiac remodeling often decompensates causing dysfunction and heart failure (HF). Cardiac remodeling and dysfunction are significantly associated with cigarette...
Main Authors: | Nicholas D. Fried, Joshua M. Oakes, Anna K. Whitehead, Eric Lazartigues, Xinping Yue, Jason D. Gardner |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.993617/full |
Similar Items
-
Assessment of nicotine delivery and uptake in users of various tobacco/nicotine products
by: Gerhard Scherer, et al.
Published: (2022-01-01) -
The development and assessment of modified Fagerstrom test for nicotine dependence scale among Malaysian single electronic cigarette users
by: Aziz Ur Rahman, et al.
Published: (2020-01-01) -
Use of tobacco, nicotine and cannabis products among students in Switzerland
by: Jana Affolter, et al.
Published: (2023-03-01) -
Monoamine oxidase inhibition in cigarette smokers: From preclinical studies to tobacco product regulation
by: Alan F. Sved, et al.
Published: (2022-08-01) -
Latent class trajectories: U.S. adolescents’ nicotine use and its association with nicotine dependence
by: Carol J. Boyd, et al.
Published: (2020-12-01)